BACKGROUND: There is increasing evidence that mitochondrial DNA (mtDNA) anomalies in sperm may lead to infertility. Point mutations, deletions and the presence of a speci®c mtDNA haplogroup have been associated with poor sperm quality, but little attention has been paid to the role of mtDNA content. METHODS: Using density gradient separation and swim-up methods, we selected motile sperm from 32 normal and 35 abnormal sperm samples. The mtDNA/b-globin gene ratio was determined by real-time quantitative PCR. RESULTS: The average mtDNA/b-globin ratio of sperm collected from 100% density layers was 1.4 for normal sperm, 6.1 for sperm samples presenting at least one abnormal criterion [among the three criteria established by World Health Organization (1999), i.e. sperm count, motility and morphology], and 9.1 for sperm samples presenting two or more of these abnormal criteria. These differences are very highly signi®cant (P < 0.0001). The mtDNA numbers were also much greater in sperm collected from the 40% density gradient layers (mean: 17.1, P < 0.001), known to contain the most abnormal sperm of the sperm samples, than in those collected from the 100% layers known to contain sperm with the best fertilizing ability. CONCLUSION: Our results showed signi®cant mtDNA ampli®cation in sperm collected from abnormal sperm samples.
Introduction
Mitochondrial DNA (mtDNA), which is maternally transmitted, is a circular double-stranded DNA molecule composed of 16.5 kilobases. mtDNA codes for 13 essential subunits of the respiratory chain complexes that provide the main ATP supply of the cell (Anderson et al., 1981) . The number of mitochondria per cell type is highly variable depending on the cell's energetic demand, with some mitochondria carrying up to 11 copies of mtDNA, whereas others may have none (Cavelier et al., 2000) . Most mammalian somatic cells contain between 10 2 and 10 4 copies of mtDNA. Human oocytes contain an average of 200 000 mtDNA copies and we have shown that the increase of mtDNA copy numbers in these cells is correlated with their fertilizability (Reynier et al., 2001) . Although oogenesis is associated with a strong ampli®cation of mtDNA copy numbers, spermatogenesis is associated with a drastic reduction in mtDNA content, to about a tenth of its initial value, occurring mainly during spermiogenesis (Hecht et al., 1984) . This reduction mainly occurs when the rounded spermatids take on an elongated form, accompanied by the loss of the residual bodies. The residual bodies, containing most of the spermatid cytoplasm, are then phagocytosed by Sertoli cells. At the molecular level, the reduction of mtDNA content is due to the down-regulation of the nuclear encoded mitochondrial transcription Factor A (tfam), which is the main factor controlling mtDNA copy number (Larsson et al., 1997) . This sharp reduction in mtDNA content, together with the action of a speci®c ubiquitination-mediated mechanism of paternal mitochondrion destruction in the early embryo (Sutovsky et al., 1999) , explains the absence of transmission of paternal mtDNA. Mature mammalian sperm are known to contain~22±75 mitochondria, which form a tight helix around the¯agellar basis of the midpiece, providing the ATP necessary for¯agellar propulsion (Bahr and Engler, 1970; St John et al., 2000a) . The few reports available on mtDNA quanti®cation in mammalian sperm present widely varying results. Thus, Hecht et al. (1984) found 50±75 mtDNA copies per mouse sperm using the semi-quantitative Southern blot method. Using the same method, Manfredi et al. (1997) estimated that each human sperm contained~1500 molecules of mtDNA. Using real-time quantitative PCR, Shitara et al. (2000) found 10 copies of mtDNA per mouse sperm, and 150 copies of mtDNA per mouse spermatid.
During the past few years, some evidence of mitochondrial involvement in male infertility has been found. First, male infertility, associated with asthenozoospermia (Folgero et al., 1993) or oligoasthenozoospermia (Lestienne et al., 1997) , has been reported in patients suffering from typical mtDNA diseases, involving point mutations or multiple deletions of mtDNA. Secondly, sperm have been shown to be particularly prone to develop deletions of mtDNA (Cummins, 1998; Cummins et al., 1998; Reynier et al., 1998; St John et al., 2001; O'Connell et al., 2002a,b) . Some studies have shown that, in human sperm, these deletions are associated with a decline of motility and fertility (Kao et al., 1995 (Kao et al., , 1998 . Thirdly, a correlation has been found between the quality of the semen and the functionality of the respiratory chain in sperm mitochondria (Ruiz-Pesini et al., 1998 Hoshi et al., 2002) . Moreover, it has been shown that mtDNA point mutations, mtDNA single nucleotide polymorphisms and mtDNA haplogroups can greatly in¯uence semen quality (Holyoake et al., 1999 (Holyoake et al., , 2001 Ruiz-Pesini et al., 2000b; Sutarno et al., 2002) . The high rate of deletions or substitutions observed in sperm could be due to impaired mitochondrial maintenance or result from the deleterious effects of oxidative stress. Recently, the nuclear encoded mitochondrial-speci®c DNA polymerase gamma (POLG) has been reported to be involved in male infertility (Rovio et al., 2001) . The absence of the most common allele of the POLG gene was found to be associated with a range of defects in sperm quality. The genotype of the nuclear encoded glutathione S-transferase M1, involved in reactive oxygen species detoxi®cation, has also been associated with male infertility and mtDNA deletion (Chen et al., 2002) . Lastly, sperm treatment with extracellular ATP has been shown to induce a signi®cant increase in the fertilizing potential of sperm, demonstrating the importance of the mitochondrial function in male fertility (Rossato et al., 1999) . In order to investigate the role of mtDNA in male infertility we have quanti®ed sperm mtDNA by means of real-time PCR.
Materials and methods

Patients and sperm samples
The Ethics Committee of the University Hospital of Angers approved the plan of our study. We collected 67 semen samples from 67 patients recruited from couples who presented for semen analysis or assisted reproductive technology at the In Vitro Fecundation Laboratory of the University Hospital of Angers, France. These couples suffered from either male or female infertility, or infertility of unknown aetiology. Semen samples were produced by masturbation after 3±5 days of abstinence. After liquefaction of the semen samples at room temperature, a standard manual protocol of analysis was used according to the criteria established by the World Health Organization (WHO) (World Health Organization, 1999) . Thirtytwo samples were classi®ed as normal (b20Q10 6 sperm/ml; type`a' motility: b25% or type`a + b' motility: b50%; and normal morphology: b30%), and 35 samples were considered abnormal (Table I) . Of the 35 abnormal sperm samples, 14 had only one abnormal criterion (among the three criteria established by the WHO corresponding to oligozoospermia, asthenozoospermia and teratozoospermia), and the remainder had two (n = 8) or more (n = 13) of these abnormal criteria. In order to eliminate seminal plasma and separate sperm according to morphology and motility, 1 ml of each semen sample was centrifuged in discontinuous three-layer Puresperm (Nidacon, Gothenburg, Sweden) density gradients (40, 60 and 100%) at 300 g for 20 min. All the 67 100% fractions, and 31 of the 40% fractions were then washed in 5 ml of Spermrinse (IVF Scandinavian, Stockholm, Sweden) and centrifuged at 600 g for 10 min. The resultant pellets were then layered with 300 ml of IVF-20 medium (IVF Scandinavian). The preparations were incubated in an atmosphere of 5% CO 2 at 37°C for 2 h, to permit the sperm to swim up. A total of 250 ml of supernatant sample was taken up. Sperm counting was performed on Kova-slide cells and the concentration was adjusted, when necessary, to <10 6 sperm per ml with 0.9% NaCl. Samples (200 ml) of each dilution were then stored at ±20°C until DNA was extracted.
Preparation of DNA DNA was extracted from each sperm sample by means of the High Pure PCR Template Preparation Kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's recommendations, except for the addition of dithiothreitol (1% DTT) in order to break the sperm nucleus disulphide bonds, and also to dissociate mitochondria from the mitochondrial sheath (Sutovsky et al., 1997; Carter et al., 2000) . Brie¯y, DNA bound speci®cally to glass ®bre following the combined action of a chaotropic agent (guanidine), a detergent (Triton X-100), the enzyme proteinase K, and the DTT. After washing, the silicabound DNA was eluted with 200 ml of pre-warmed (72°C) elution buffer and preserved at 4°C.
mtDNA/b-globin real-time PCR quanti®cation
The external standard used for mtDNA quanti®cation was a 158 bp PCR product. The nucleotide positions of the primers on the light strand mtDNA (according to the Cambridge reference sequence) Increased sperm mtDNA content in male infertility were: D41 (3254±3277) and D56 (3126±3147). PCR reactions were carried out under standard conditions with 100 ng of total DNA in a 50 ml volume: 1.5 mmol/l MgCl 2 , 75 mmol/l Tris±HCl (pH 9 at 25°C), 20 mmol/l (NH 4 ) 2 SO 4 , 0.01% Tween 20, 50 pmol of each primer, 200 mmol/l of each dNTP and 2 IU of GoldStar DNA polymerase (Eurogentec, Seraing, Belgium). Each of 35 cycles consisted of a denaturation step of 30 s at 94°C, a hybridization step of 30 s at 58°C, and an extension step of 1 min at 72°C. The PCR product was phenol±chloroform puri®ed from low melting point agarose and cloned using the Topo TA Cloning Kit (Invitogen, Life Technologies, Groningen, The Netherlands) into pCR 2.1-Topo â vector. The recombinant plasmid was puri®ed using Qia Prep Spin Miniprep Kit (Qiagen, Courtaboeuf, France) and was quanti®ed by spectrophotometry. Puri®cation quality was checked by means of the 260/ 280 absorbance ratio, and the absence of residual bacterial DNA was checked by agarose gel electrophoresis. It was assumed that 1 mg of a 4066 bp product (vector 3908 bp and insert 158 bp) contained 2.2Q10 11 molecules. Serial dilutions were then made in order to assess several concentrations of a known number of templates. These serial dilutions were used as the external standard for real-time PCR. The serial dilutions were all stored at ±20°C in single-use aliquots. A Roche LightCycler was used to determine the mtDNA copy number using LightCycler-Faststart DNA master SYBR Green 1 kit (Roche). A total of 20 ml PCR reaction mixtures were prepared as follows: 1Qbuffer containing 4 mmol/l MgCl 2 , 0.2 mmol/l dNTP, 0.5 mmol/l of both primers (D41 and R56), SYBR green I dye, 0.25 IU hot start Taq DNA polymerase and 10 ml of the extracted DNA or 10 ml of Standard with a known copy number. The reactions were performed as follows: initial denaturing at 95°C for 7 min and 40 cycles at 95°C for 1 s, 58°C for 5 s, and 72°C for 13 s. The SYBR green¯uorescence was read at the end of each extension step (72°C). A melting curve (loss of uorescence at a given temperature between 66°C and 94°C) was analysed in order to check the speci®city of the PCR product. For each run, a standard curve (log of the initial template copy number on the abscissa, and the cycle number at the crossing point on the ordinates) was generated using ®ve 10-fold serial dilutions (10±100 000 copies) of the external standard (Figure 1 ). This curve allowed the determination of the starting copy number of mtDNA in each sample. All samples were tested twice.
In order to determine the number of sperm in each sample, we quanti®ed the b-globin gene by means of the LightCycler-Control Kit DNA (Roche) according to the manufacturer's recommendations. Brie¯y, a 110 bp fragment of the b-globin gene was ampli®ed using human genomic DNA as a standard. PCR reaction mixtures (18 ml) were added to 2 ml of the extracted DNA or to 2 ml of Standard with a known b-globin copy number. The reactions were performed on the LightCycler as follows: initial denaturing at 95°C for 7 min and 40 cycles at 95°C for 1 s, 55°C for 5 s, and 72°C for 10 s. The SYBR green¯uorescence was read at the end of each extension step (72°C). The melting curve analysis was systematically performed. For each run, a standard curve was generated using ®ve 10-fold serial dilutions (1±10 000 copies) of the Standard. The standard curve generated by the LightCycler software (version 3.5) allowed the determination of the starting copy number of b-globin gene in each sample. All samples were tested twice.
The calculation of mtDNA/b-globin ratio was performed taking into account the volume of the extracted DNA used as a template for PCR ampli®cation (10/200 ml for mtDNA PCR and 2/200 ml for bglobin PCR).
Statistical analysis
The various groups of sperm were compared using the non-parametric Mann±Whitney, Kruskal±Wallis and Wilcoxon U-tests and the Student's t-test with Systat software, version 8.0 (SPSS Inc., Chicago, IL, USA). Differences were considered signi®cant when P < 0.05.
Results
In order to compare the mtDNA content of normal and abnormal sperm, we eliminated round cells using a combined density gradient layer and a swim-up method capable of selecting only motile sperm. The absence of round cells in our sperm preparations was checked by light microscopy. The accurate quanti®cation of mtDNA depends closely on the high recovery of mtDNA templates. We have shown that the DNA extraction technique used in the present study allows the recovery of >93% of the mtDNA (Reynier et al., 2001) . The correspondence between the results of the microscopic count of sperm (average: 83 220) and the b-globin gene quanti®cation (average: 80 171) also demonstrated the ef®ciency of the mtDNA extraction (Student's test: P = not signi®cant, and r = 0.85, P = 0.23). As shown by the linearity of the standard curve ( Figure 1A) , the mtDNA PCR ef®ciency was constant over the concentration range studied (10±100 000 copies). Moreover, as shown by the standard curve obtained with three 10-fold dilutions of sperm extract which had the same slope as that obtained with standard dilutions (±3.49 and ±3.48 respectively), the PCR ef®ciency was almost the same for the standards as for the sperm extracts ( Figure 1B) . The intra-assay precision of the mtDNA and b-globin quanti®cation was assessed from 10 measurements of four different sperm DNA samples; the coef®cients of variation (CV) were between 5.5 and 8.9% (Table II) . The repeatability between runs (interassay) was assessed from ®ve measurements of four different sperm DNA samples; the CV were between 6.5 and 12.8% (Table III) .
The mtDNA/b-globin ratio, expressing the average copy number per haploid genome or per sperm, was determined for 98 sperm extracts (67 100% layers and 31 40% layers) obtained from the 67 ejaculates (Table I) . The average ratio, 10.1 (0.3±70.4), varied considerably. The average mtDNA copy number per sperm was 3.8 in the 67 groups of sperm isolated from 100% density layers. The average ratio was 1.4 (0.3±4.2) in the group of 32 patients with normal sperm, compared with 6.1 (0.5±28.0) in the group of 35 patients showing at least one abnormal WHO criterion (Table I ). The non-parametric Mann±Whitney U-test showed that this difference was highly signi®cant (P < 0.0001) (Figure 2 ). The average mtDNA/bglobin ratio in the group of 14 patients with only one abnormal WHO criterion was 1.5 (0.5±6.0). This was not signi®cantly different from the average ratio found in the normal group. The average mtDNA/b-globin ratio was 9.1 (0.8±28.0) in the group of 21 patients with two or more abnormal WHO criteria. This was signi®cantly different from that of the normal group (1.4) on the Kruskal±Wallis U-test (P < 0.0001) (Figure 3) . The mtDNA contents of two different density gradient fractions (40 and 100%) were also compared, two by two, for each of 31 patients without taking into account the initial sperm quality (Table IV) . The Wilcoxon U-test showed that the mtDNA content was signi®cantly higher (P < 0.001) (Figure 4 ) in the 40% layers (mean: 17.1; range: 0.8±70.4) than in the 100% layers (mean: 2.4; range 0.3±12.8).
Discussion
The determination of mtDNA/b-globin gene ratios using realtime quantitative PCR revealed that the average mtDNA copy number in motile human sperm was 10.1. This value is close to that found by Shitara et al. (2000) who, using a similar quantitative PCR technique, found an average of 10 mtDNA copies per mouse sperm. However, these results differ Increased sperm mtDNA content in male infertility considerably from the values indicated by Hecht et al. (1984) who found 50±75 mtDNA copies per mouse sperm, and of Manfredi et al. (1997) who estimated that each human sperm contained~1500 mtDNA copies. One explanation for these discordant results may lie in the use of the different methods of quantifying the mitochondrial genome. Indeed, the Southern blot method may lead to cross-hybridization with the large number of mitochondrial pseudogenes (~300) recently found in the nuclear genome (Mourier et al., 2001; Tourmen et al., 2002; Woischnik and Moraes, 2002 ). These nuclear pseudogenes share high levels of similarity with mtDNA and might have been erroneously recognized by the wide-ranging mtDNA probes such as those used in the Southern blot technique. In contrast, our PCR method was demonstrated to be mtDNAspeci®c since no false ampli®cation of nuclear pseudogenes in cells without mtDNA was detected. Another explanation for the discrepancy of the various results reported might lie in the presence of round cells (mainly germinal cells and leukocytes) in the sperm preparations. Contamination by only a few of these cells, which have an mtDNA content exceeding that of sperm by a factor of >100, could easily lead to a serious overestimation of mtDNA content in sperm. In order to avoid this bias, we used a combination of density gradient centrifugation, which allowed partial elimination of round cells by retaining them at the 40±60% layer interface (Gandini et al., 1999) , and of the swim-up technique. These combined techniques allowed us to obtain sperm samples completely free of contaminating round cells. The motile sperm extracted from normal sperm samples were found to contain only 1.4 mtDNA molecules on average. This means that the majority of sperm mitochondria are almost totally devoid of mtDNA, and that many sperm probably do not contain any mtDNA at all. It has been shown that the paternal mtDNA, found in the early embryonic stages, is rapidly eliminated, and we suggest that the lack of mtDNA content in some sperm with the best fertilizing ability may also explain why the mitochondrial genome is not paternally transmitted. The functionality of the respiratory chain must therefore be temporally maintained in mature sperm until fertilization, despite the quasi-absence of mtDNA in their mitochondria. Indeed, it has been shown that mtRNA transcripts remain highly stable, and that the translation of mtRNA into subunits of the respiratory chain continues actively in the mitochondria of sperm, despite the complete absence of mtDNA replication (Rantanen and Larsson, 2000) . Point mutations, deletions or haplogroups of mtDNA could be involved in male infertility. In the present report we show that highly signi®cant mtDNA ampli®cation was found in abnormal sperm, highlighting the multiple implications of mitochondria in male infertility. First, the mtDNA content of motile sperm was found to be up to 28 times higher in sperm samples of poor quality than in normal sperm samples. Secondly, sperm collected from the 40% layers (which contain a majority of abnormal sperm) were found to have an mtDNA content up to 70-fold greater than that of sperm collected from the 100% layers (which contain sperm with the best fertilizing ability). This mtDNA ampli®cation could have two main causes. One could be a feedback process operating to compensate low respiratory chain activity, thus leading to an increase of mtDNA. Indeed, such compensatory processes of increased mitochondrial biogenesis are frequently observed in mitochondrial pathology. Another cause of mtDNA ampli®ca-tion could be the abnormal differentiation and maturation of sperm in infertile patients. In fact, mtDNA ampli®cation was more signi®cant in sperm samples with at least two abnormal WHO criteria, suggesting a global disorder of spermatogenesis. We therefore postulate that insuf®cient mtDNA copy number reduction may occur when the maturation of sperm is perturbed.
In conclusion, our study shows that sperm mtDNA is strongly ampli®ed in sperm samples from infertile patients presenting abnormal sperm characteristics. This raises the question about the risks involved in the use of a number of methods of assisted procreation, such as ICSI and round spermatid injection. These techniques involve the treatment of extreme cases of male infertility by means of sperm that may be abnormal, and immature sperm or sperm precursors (such as spermatids and spermatocytes) obtained from testicular biopsies, all of which have a higher mtDNA content than mature sperm. Furthermore it has been shown that oocytes from aged women or from women with ovarian de®ciencies may have defective mtDNA genetic ®lters (St John et al., 1997) . Although the ®rst studies on mtDNA inheritance after ICSI suggest that human embryos eliminate the mtDNA of the injected sperm (Danan et al., 1999) , one study has recently shown that abnormal paternal mtDNA transmission may not be uncommon when poor-quality gametes are used (St John et al., 2000b) . Thus, at present, it cannot be precluded that the intracytoplasmic injection of sperm with ampli®ed mtDNA into defective oocytes may impair the mechanism of elimination of paternal mtDNA, thereby further jeopardizing embryonic development and mitochondrial inheritance.
